Bed estimates of HIV incidence: Resolving the differences, making things simpler

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Hargrove, John ^a   van Schalkwyk, Cari ^a   Eastwood, Hayden ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; BED CAPTURE ENZYME IMMUNOASSAY; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; POPULATION DYNAMICS; SEROCONVERSION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LIGHT RELATED PHENOMENA; METHODOLOGY; PATHOGENICITY; TIME;

BIOLOGICAL MARKER; IMMUNOGLOBULIN G;

BIOLOGICAL MARKERS; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; INCIDENCE; OPTICAL PROCESSES; TIME FACTORS;

EID: 84855384957     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029736     Document Type: Article

References (14)

1. Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, et al. (2002) Quantitative detection of increasing HIV type 1 antibodies after seroconversion: A simple assay for detecting recent HIV infection and estimating incidence. AIDS Research and Human Retroviruses 18: 295-307.
2. UNAIDS Statement on the use of the BED-assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring; 2005 December 13-15; Geneva.
3. Hargrove JW, Humphrey JH, Mutasa K, Parekh BS, McDougal JS, et al. (2008) Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS 22: 511-518.
4. McDougal JS, Parekh BS, Peterson ML, Branson BM, Dobbs T, et al. (2006) Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Research and Human Retroviruses 22: 945-952.
5. Brookmeyer R, (2009) Should biomarker estimates of HIV incidence be adjusted? AIDS 23: 485-491.
6. Hargrove JW, (2009) BED estimates of HIV incidence must be adjusted. AIDS 23: 2061-2062.
7. Welte A, McWalter TA, Barnighausen T, (2009) Reply to 'Should biomarker estimates of HIV incidence be adjusted?' AIDS 23: 2062-2063.
8. McDougal JS, (2009) BED estimates of HIV incidence must be adjusted. AIDS 23: 2064-2065.
9. Brookmeyer R, (2009) Response to correspondence on 'Should biomarker estimates of HIV incidence be adjusted?' AIDS 23: 2066-2068.
10. McWalter TA, Welte A, (2010) Relating recent infection prevalence to incidence with a sub-population of assay non-progressors. Journal of Mathematical Biology 60: 687-710.
11. Welte AMT, Kassanjee R, Bärnighausen T, (2011) Derivation and calibration of a new general class of biomarker-based incidence estimators. Epidemiology (submitted).
12. McWalter TA, Welte A, (2009) A comparison of biomarker based incidence estimators. PLoS One Available: http://wwwplosoneorg/article/info:doi/101371/journalpone0007368. Accessed 2011 Dec 8.
13. Parekh BS, Hanson DL, Hargrove J, Branson B, Green T, et al. (2011) Determination of mean recency period for estimation of HIV Type 1 incidence with the BED-Capture EIA in persons infected with diverse subtypes. AIDS Research and Human Retroviruses 27: 265-273.
14. Brookmeyer R, (2010) Measuring the HIV/AIDS epidemic: approaches and challenges. Epidemiologic Reviews 32: 26-37.